NJ Reglan Ruling Widens Generic Label Preemption Split
The New Jersey Supreme Court's ruling on Monday that state law claims alleging generic-drug manufacturers didn't adequately warn of neurological risks for Reglan aren't preempted by federal law widens an emerging...To view the full article, register now.
Already a subscriber? Click here to view full article